Compare TWST & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | UHS |
|---|---|---|
| Founded | 2013 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 10.5B |
| IPO Year | 2018 | 1994 |
| Metric | TWST | UHS |
|---|---|---|
| Price | $154.09 | $175.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 20 |
| Target Price | $168.25 | ★ $192.41 |
| AVG Volume (30 Days) | ★ 2.8M | 566.3K |
| Earning Date | 11-12-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 0.45% |
| EPS Growth | ★ 63.89 | 37.34 |
| EPS | N/A | ★ 11.63 |
| Revenue | $376,572,000.00 | ★ $17,364,829,000.00 |
| Revenue This Year | $21.17 | $7.17 |
| Revenue Next Year | $20.24 | $4.68 |
| P/E Ratio | ★ N/A | $15.16 |
| Revenue Growth | ★ 20.32 | 9.71 |
| 52 Week Low | $23.30 | $140.08 |
| 52 Week High | $219.71 | $246.33 |
| Indicator | TWST | UHS |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 45.28 |
| Support Level | $122.05 | $173.59 |
| Resistance Level | $155.44 | $176.99 |
| Average True Range (ATR) | 13.90 | 6.28 |
| MACD | 1.25 | -1.28 |
| Stochastic Oscillator | 45.60 | 29.37 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Universal Health Services Inc offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the U.S, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.